Ayurveda Management of Irritable Bowel Syndrome

Efficacy of Whole System Research Ayurveda Interventions on Irritable Bowel Syndrome â??Randomized Controlled Clinical Trail.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/01/011628

Enrollment

Registered

2018-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome Health Condition 2: null- Rome IV Criteria for diagnosing IBS

Interventions

Intervention1: Whole system Approach like kutaja ghana vati: Kutaja ghana vati 500 mg orally three times a day for 60 days Control Intervention1: Kalingadi churna: 3 gm twice a day orally for 60 days

Eligibility

Inclusion criteria

Inclusion criteria: 1.Individuals between the age group of 20 to 60 years fulfilling diagnostic criteria for IBS(Rome IV) of either sex. 2.Either sex.

Exclusion criteria

Exclusion criteria: 1.Patient on any Intervention for IBS in the period of last 4 weeks 2.Patients with known/history of Carcinoma Colon, ulcerative colitis 3.Patients with alcohol dependency or drug dependency. 4.Pregnant or lactating women 5.Patients suffering from major systemic illness necessitating long term drug treatment, Rheumatoid arthritis, tuberculosis, etc

Design outcomes

Primary

Measure	Time frame
1.IBS Adequate Relief (IBS-AR) 2.IBS Symptom Severity Score (IBS-SSS) Timepoint: 60th day	—

Secondary

Measure	Time frame
1.Abdominal Pain- VAS (0-10) 2.Stool Consistency- Bristol Stool Form (BSF) 3.Stool frequency- Numbers/day 4..Complete Spontaneous Bowel Movements (CSBMs)- Constipation 5.IBS global improvement Scale (IBS-GIS) 6.IBS quality of life (IBS-QOL) - 7.Gastrointestinal symptom rating scale (GSRS) 8.Hamilton Anxiety Rating Scale 9.Hamilton Depression Rating Scale Timepoint: 60th day	—

Countries

India

Contacts

Public ContactDr Basavaraj R Tubaki

KAHER

ayurbasavaraj@gmail.com9448634660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026